copper sulfate has been researched along with Elevated Cholesterol in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernvik, EC; Gidlund, M; Ketelhuth, DF; Russo, M | 1 |
| Kempaiah, RK; Manjunatha, H; Srinivasan, K | 1 |
| Bifulco, M; Gioielli, A; Milone, A; Mondola, P; Santillo, M | 1 |
| Aviram, M; Hussein, O; Keidar, S; Rosenblat, M; Schlezinger, S | 1 |
| Malminiemi, K; Malminiemi, O; Palomäki, A; Solakivi, T | 1 |
1 trial(s) available for copper sulfate and Elevated Cholesterol
| Article | Year |
|---|---|
Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo.
Topics: Analysis of Variance; Anticholesteremic Agents; Antioxidants; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Copper Sulfate; Coronary Disease; Cross-Over Studies; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Triglycerides; Ubiquinone | 1998 |
4 other study(ies) available for copper sulfate and Elevated Cholesterol
| Article | Year |
|---|---|
The autoantibody repertoire against copper- or macrophage-modified LDL differs in normolipidemics and hypercholesterolemic patients.
Topics: Animals; Autoantibodies; Case-Control Studies; Chromatography, Ion Exchange; Copper Sulfate; Coronary Artery Disease; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Middle Aged; Oxidation-Reduction | 2004 |
Protective effect of dietary capsaicin on induced oxidation of low-density lipoprotein in rats.
Topics: Animals; Antioxidants; Capsaicin; Cholesterol, Dietary; Copper Sulfate; Diet; Diet, Atherogenic; Electrophoresis, Agar Gel; Female; Hypercholesterolemia; Lipid Peroxidation; Lipoproteins, LDL; Oxidation-Reduction; Protective Agents; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2005 |
Ascorbate administration to normal and cholesterol-fed rats inhibits in vitro TBARS formation in serum and liver homogenates.
Topics: Animals; Ascorbic Acid; Body Weight; Cholesterol, Dietary; Copper; Copper Sulfate; Fatty Acids; Hypercholesterolemia; Lipid Peroxidation; Lipid Peroxides; Liver; Male; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 1996 |
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL.
Topics: Adult; Aged; Amidines; Anticholesteremic Agents; Copper Sulfate; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Free Radical Scavengers; Humans; Hypercholesterolemia; Indoles; Lipid Peroxidation; Lipids; Lipoproteins, LDL; Middle Aged | 1997 |